Benzphetamine tablets — Class III drug recall D-1123-2022
Terminated recall by Calvin Scott & Company, Inc., reported 2022-06-01. Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets an
| Recall number | D-1123-2022 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Calvin Scott & Company, Inc., Albuquerque, NM, United States |
| Recall initiated | 2021-01-15 |
| Classified | 2022-06-09 |
| Reported by FDA | 2022-06-01 |
| Terminated | 2022-11-08 |
| Quantity | 13 bottles |
| Reason classes | labeling |
| NDC | 10702-0040-50 |
| Lot numbers | 5/22, CS-20274-005 |
Product
Benzphetamine tablets, 50mg, CIII, repackaged in 30-count bottles, Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123, NDC 10702-0040-50
Reason for recall
Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1123-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.